您是第 11158638 位 欢迎访问 中乔新舟官网 ! 全国免费电话:400-038-9959 我的购物车(0) 注 册 / 登 录
扫码关注公众号
您当前的位置:首页 > 产品中心

SUP-T1人T淋巴瘤细胞(STR鉴定)

英文名:SUP-T1
货号:ZQ0839
价格:¥4000.00
加入购物车,提交订单信息之后,我们会第一时间与您取得联系!
推荐组合

SUP-T1人T淋巴瘤细胞(STR鉴定)

¥4000.00
+

SUP-T1人T淋巴瘤细胞专用培养基

¥350.00 ¥500.00

配套完培,组合使用,省时省力!

=

细胞套餐惊爆价

¥4350 ¥5300.00
加入购物车
  • 产品说明
  • 产品规格
  • 参考文献
  • STR鉴定

产品名称

SUP-T1人T淋巴瘤细胞

货号

ZQ0839

产品介绍

该系来源于从患有 T 细胞淋巴细胞淋巴瘤的 8 岁儿童的恶性胸腔积液中收集的恶性细胞。细胞的形态为淋巴母细胞样,生长方式为悬浮生长。SUP-T1细胞系被广泛用于癌症研究,包括药物筛选、基因表达研究、细胞信号传导研究等。也用于研究T细胞急性淋巴细胞白血病(T-ALL)的发生、发展,以及Notch1基因表达对T-ALL细胞增殖及硼替佐米敏感性的影响。

种属

性别/年龄

/8岁

组织

白血病;淋巴细胞;T 淋巴母细胞

疾病

淋巴母细胞淋巴瘤;T细胞

细胞类型

T淋巴母细胞

形态学

淋巴母细胞

生长方式

悬浮

倍增时间

大约28 hours (PubMed=3004618); ~30 hours (DSMZ=ACC-140); ~24-36 hours (HIVReagentProgram=ARP-100)

培养基和添加剂

RPMI-1640(品牌:中乔新舟 货号:ZQ-200+10%胎牛血清(中乔新舟 货号:ZQ0500+1%P/S(中乔新舟  货号:CSP006

推荐完全培养基货号

ZM0839

生物安全等级

BSL-1

培养条件

95%空气,5%二氧化碳;37℃

STR位点信息

Amelogenin :X (DSMZ=ACC-140)

                     :X,Y (ATCC=CRL-1942; Cosmic-CLP=909743;                                                      PubMed=32938764)

CSF1PO 10,11 (ATCC=CRL-1942; Cosmic-CLP=909743; DSMZ=ACC-140)

             :10,11,12 (PubMed=32938764)

D2S1338 25,26

D3S1358 16,17,18,19 (PubMed=32938764)

               :17 (DSMZ=ACC-140)

D5S818 10,11,12 (DSMZ=ACC-140)

              :11 (PubMed=32938764)

              :11,12 (ATCC=CRL-1942; Cosmic-CLP=909743)

D7S820 11

D8S1179 13,14 (PubMed=32938764)

               :13,14,15 (DSMZ=ACC-140)

D13S317 10,11,12 (DSMZ=ACC-140; PubMed=32938764)

               :11,12 (ATCC=CRL-1942; Cosmic-CLP=909743)

D16S539 9,10,11,13 (DSMZ=ACC-140)

               :9,11,12 (ATCC=CRL-1942; Cosmic-CLP=909743)

               :9,12 (PubMed=32938764)

D18S51 13,14

D19S433 13,27

D21S11 28,29,32.2,33.2 (DSMZ=ACC-140)

              :28,31,32,33 (PubMed=32938764)

FGA 19,20,21 (PubMed=32938764)

        :20,21 (DSMZ=ACC-140)

Penta D 12

Penta E 13,14,16 (PubMed=32938764)

             :14,16 (DSMZ=ACC-140)

TH01 9.3

TPOX 8,9 (DSMZ=ACC-140)

           :9 (ATCC=CRL-1942; Cosmic-CLP=909743; PubMed=32938764)

vWA 16,17,18,19 (PubMed=32938764)

       :16,18 (ATCC=CRL-1942; Cosmic-CLP=909743)

抗原表达/受体表达

*** 

基因表达

*** 

保藏机构

ATCC

供应限制

仅供科研使用


货号

ZQ0839

发货规格

活细胞:T25培养瓶*1瓶或者1ml 冻存管*1支(细胞量约为5 x 10^5 cells/vial)二选一

发货形式

活细胞:常温运输;冻存管:干冰运输

储存温度

活细胞:培养箱;冻存管:液氮罐

产地

中国

供应限制

仅供科研使用

PubMed=6437672
Smith S.D., Shatsky M., Cohen P.S., Warnke R.A., Link M.P., Glader B.E.
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines.
Cancer Res. 44:5657-5660(1984)


PubMed=6438800; DOI=10.1126/science.6438800
Hecht F., Morgan R., Kaiser-McCaw Hecht B., Smith S.D.
Common region on chromosome 14 in T-cell leukemia and lymphoma.
Science 226:1445-1447(1984)


PubMed=3935328; DOI=10.1016/0092-8674(85)90243-0
Baer R., Chen K.-C., Smith S.D., Rabbitts T.H.
Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors.
Cell 43:705-713(1985)


PubMed=3004618; DOI=10.1182/blood.V67.3.650.650
Smith S.D., Morgan R., Link M.P., McFall P., Hecht F.
Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma.
Blood 67:650-656(1986)


PubMed=3010463; DOI=10.1126/science.3010463
Lifson J.D., Reyes G.R., McGrath M.S., Stein B.S., Engleman E.G.
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.
Science 232:1123-1127(1986)


PubMed=3036367; DOI=10.1016/0092-8674(87)90666-0
Baer R., Forster A., Rabbitts T.H.
The mechanism of chromosome 14 inversion in a human T cell lymphoma.
Cell 50:97-105(1987)


PubMed=3107838; DOI=10.1016/0092-8674(87)90542-3
Stein B.S., Gowda S.D., Lifson J.D., Penhallow R.C., Bensch K.G., Engleman E.G.
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.
Cell 49:659-668(1987)


PubMed=7849311; DOI=10.1182/blood.V85.4.893.bloodjournal854893
Stranks G., Height S.E., Mitchell P., Jadayel D.M., Yuille M.A.R., De Lord C., Clutterbuck R.D., Treleaven J.G., Powles R.L., Nacheva E., Oscier D.G., Karpas A., Lenoir G.M., Smith S.D., Millar J.L., Catovsky D., Dyer M.J.S.
Deletions and rearrangement of CDKN2 in lymphoid malignancy.
Blood 85:893-901(1995)


PubMed=8558920
Dirks W.G., Zaborski M., Jager K., Challier C., Shiota M., Quentmeier H., Drexler H.G.
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Leukemia 10:142-149(1996)


PubMed=9933131; DOI=10.1016/S0145-2126(98)00133-7
Burger R., Hansen-Hagge T.E., Drexler H.G., Gramatzki M.
Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies.
Leuk. Res. 23:19-27(1999)


DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001)


PubMed=11264379; DOI=10.1128/JVI.75.8.3903-3915.2001
Means R.E., Matthews T., Hoxie J.A., Malim M.H., Kodama T., Desrosiers R.C.
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
J. Virol. 75:3903-3915(2001)


PubMed=17170727; DOI=10.1038/sj.leu.2404486
Sandberg Y., Verhaaf B., van Gastel-Mol E.J., Wolvers-Tettero I.L.M., De Vos J., MacLeod R.A.F., Noordzij J.G., Dik W.A., van Dongen J.J.M., Langerak A.W.
Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes.
Leukemia 21:230-237(2007)


PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)


PubMed=22292511; DOI=10.2174/187221512799303172
Ho P., Dai K.-S., Chen H.-L.
Molecular cloning of a novel PPEF-1 gene variant from a T-cell lymphoblastic lymphoma cell line.
Recent Pat. DNA Gene Seq. 6:72-77(2012)


PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)


PubMed=22675565; DOI=10.1371/journal.pone.0038463
Atak Z.K., De Keersmaecker K., Gianfelici V., Geerdens E., Vandepoel R., Pauwels D., Porcu M., Lahortiga I., Brys V., Dirks W.G., Quentmeier H., Cloos J., Cuppens H., Uyttebroeck A., Vandenberghe P., Cools J., Aerts S.
High accuracy mutation detection in leukemia on a selected panel of cancer genes.
PLoS ONE 7:E38463-E38463(2012)


PubMed=25355872; DOI=10.1128/JVI.02570-14
Cao S.-B., Strong M.J., Wang X., Moss W.N., Concha M., Lin Z., O'Grady T., Baddoo M., Fewell C., Renne R., Flemington E.K.
High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.
J. Virol. 89:713-729(2015)


PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)


PubMed=29304865; DOI=10.1186/s12985-017-0917-z
Becerra-Artiles A., Santoro T., Stern L.J.
Evaluation of a method to measure HHV-6B infection in vitro based on cell size.
Virol. J. 15:4.1-4.15(2018)


PubMed=30285677; DOI=10.1186/s12885-018-4840-5
Tan K.-T., Ding L.-W., Sun Q.-Y., Lao Z.-T., Chien W., Ren X., Xiao J.-F., Loh X.-Y., Xu L., Lill M., Mayakonda A., Lin D.-C., Yang H., Koeffler H.P.
Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.
BMC Cancer 18:940.1-940.13(2018)


PubMed=30629668; DOI=10.1371/journal.pone.0210404
Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.
Screening human cell lines for viral infections applying RNA-Seq data analysis.
PLoS ONE 14:E0210404-E0210404(2019)


PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)


PubMed=31068700; DOI=10.1038/s41586-019-1186-3
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)


PubMed=32938764; DOI=10.1128/JVI.01334-20
Fernandez M.V., Hoffman H.K., Pezeshkian N., Tedbury P.R., van Engelenburg S.B., Freed E.O.
Elucidating the basis for permissivity of the MT-4 T-cell line to replication of an HIV-1 mutant lacking the gp41 cytoplasmic tail.
J. Virol. 94:e01334.20.1-e01334.20.27(2020)


PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

暂无相关产品!
公司简介 / Company profile
上海中乔新舟生物科技有限公司
Shanghai Zhong Qiao Xin Zhou Biotechnology Co.,Ltd.
      上海中乔新舟生物科技有限公司(官网:www.zqxzbio.com)成立于2011年,历经十多年发展,...
联系我们 / Contact
电 话:021-56760357;021-56760351
邮 箱:sales@zqxzbio.com
邮 编:200439
地 址:上海市宝山区长江南路180号
Copyright © 2014 ZQXZBIO All rights reserved. 网站地图

沪公网安备 31011002001038号

技术支持:攸攸网络 沪ICP备14008091号